All News

As life sciences investors shy away from drug development and opt for lower-risk devices and diagnostics, what can Europe learn from Israel’s experience?

The European Commission is to boost funding for high-risk futuristic research in ICT, to provide foundations for economic recovery and future competitiveness.

Liverpool University has been awarded £3.5 million to improve knowledge transfer capabilities between academic researchers and industrial partners.

Can anybody spare a dime for science? With the usual funding avenues blocked development-stage companies are turning to research charities.

The UK government has announced a £750 million fund to help companies through the recession, with £250 million reserved for green technologies.

GlaxoSmithKline (GSK) and Pfizer are spinning out all HIV/AIDS-related R&D and marketed drugs into a separate, jointly-controlled company.

Private equity and venture capital investment by UK-based firms in 2008 fell below £20 billion for the first time since 2005, says a new report.